Balaxi Pharmaceuticals Limited

NSEI:BALAXI 株式レポート

時価総額:₹4.0b

Balaxi Pharmaceuticals バランスシートの健全性

財務の健全性 基準チェック /46

Balaxi Pharmaceuticalsの総株主資本は₹2.2B 、総負債は₹303.3Mで、負債比率は14.1%となります。総資産と総負債はそれぞれ₹2.9Bと₹721.0Mです。 Balaxi Pharmaceuticalsの EBIT は₹457.0Mで、利息カバレッジ比率24.8です。現金および短期投資は₹608.7Mです。

主要情報

14.1%

負債資本比率

₹303.30m

負債

インタレスト・カバレッジ・レシオ24.8x
現金₹608.67m
エクイティ₹2.16b
負債合計₹720.97m
総資産₹2.88b

財務の健全性に関する最新情報

Recent updates

Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

Nov 13
Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

May 29
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Feb 10
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Feb 09
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

Aug 08
Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

May 20
The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Feb 03
A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Sep 06
Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Jun 03
Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 12
Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 27
Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

財務状況分析

短期負債: BALAXIの 短期資産 ( ₹2.4B ) が 短期負債 ( ₹693.2M ) を超えています。

長期負債: BALAXIの短期資産 ( ₹2.4B ) が 長期負債 ( ₹27.7M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: BALAXI総負債よりも多くの現金を保有しています。

負債の削減: BALAXIの負債対資本比率は、過去 5 年間で0%から14.1%に増加しました。

債務返済能力: BALAXIの 営業キャッシュフロー はマイナスであるため、負債は十分にカバーされていません。

インタレストカバレッジ: BALAXIの負債に対する 利息支払いEBIT ( 24.8 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘